149 related articles for article (PubMed ID: 15039289)
21. Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.
Coutts RT; Bolaji OO; Su P; Baker GB
Drug Metab Dispos; 1994; 22(5):756-60. PubMed ID: 7835228
[TBL] [Abstract][Full Text] [Related]
22. 3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid.
Deo AK; Bandiera SM
Drug Metab Dispos; 2009 Sep; 37(9):1938-47. PubMed ID: 19487251
[TBL] [Abstract][Full Text] [Related]
23. Is toxicity of PMMA (paramethoxymethamphetamine) associated with cytochrome P450 pharmacogenetics?
Vevelstad M; Øiestad EL; Bremer S; Bogen IL; Zackrisson AL; Arnestad M
Forensic Sci Int; 2016 Apr; 261():137-47. PubMed ID: 26930544
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes.
Zhu M; Zhao W; Jimenez H; Zhang D; Yeola S; Dai R; Vachharajani N; Mitroka J
Drug Metab Dispos; 2005 Apr; 33(4):500-7. PubMed ID: 15640381
[TBL] [Abstract][Full Text] [Related]
25. Fenproporex N-dealkylation to amphetamine--enantioselective in vitro studies in human liver microsomes as well as enantioselective in vivo studies in Wistar and Dark Agouti rats.
Kraemer T; Pflugmann T; Bossmann M; Kneller NM; Peters FT; Paul LD; Springer D; Staack RF; Maurer HH
Biochem Pharmacol; 2004 Sep; 68(5):947-57. PubMed ID: 15294457
[TBL] [Abstract][Full Text] [Related]
26. Development of an in vitro incubation procedure for screening of CYP2D6 intrinsic clearance.
Porter SE; Keithley RB; Rutan SC
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):74-82. PubMed ID: 17127110
[TBL] [Abstract][Full Text] [Related]
27. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation.
Akutsu T; Kobayashi K; Sakurada K; Ikegaya H; Furihata T; Chiba K
Drug Metab Dispos; 2007 Jan; 35(1):72-8. PubMed ID: 17020955
[TBL] [Abstract][Full Text] [Related]
28. Coumarin substrates for cytochrome P450 2D6 fluorescence assays.
Nakamura K; Hanna IH; Cai H; Nishimura Y; Williams KM; Guengerich FP
Anal Biochem; 2001 May; 292(2):280-6. PubMed ID: 11355862
[TBL] [Abstract][Full Text] [Related]
29. The use of 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes.
Chauret N; Dobbs B; Lackman RL; Bateman K; Nicoll-Griffith DA; Stresser DM; Ackermann JM; Turner SD; Miller VP; Crespi CL
Drug Metab Dispos; 2001 Sep; 29(9):1196-200. PubMed ID: 11502727
[TBL] [Abstract][Full Text] [Related]
30. Identification of cytochrome P450 enzymes involved in the metabolism of 4'-methoxy-alpha-pyrrolidinopropiophenone (MOPPP), a designer drug, in human liver microsomes.
Springer D; Staack RF; Paul LD; Kraemer T; Maurer HH
Xenobiotica; 2003 Oct; 33(10):989-98. PubMed ID: 14555336
[TBL] [Abstract][Full Text] [Related]
31. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
Kitamura A; Mizuno Y; Natsui K; Yabuki M; Komuro S; Kanamaru H
Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261
[TBL] [Abstract][Full Text] [Related]
32. Identification of human hepatic cytochrome p450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid.
Deo AK; Bandiera SM
Drug Metab Dispos; 2008 Oct; 36(10):1983-91. PubMed ID: 18583509
[TBL] [Abstract][Full Text] [Related]
33. Biotransformation of lithocholic acid by rat hepatic microsomes: metabolite analysis by liquid chromatography/mass spectrometry.
Deo AK; Bandiera SM
Drug Metab Dispos; 2008 Feb; 36(2):442-51. PubMed ID: 18039809
[TBL] [Abstract][Full Text] [Related]
34. The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6.
Bachus R; Bickel U; Thomsen T; Roots I; Kewitz H
Pharmacogenetics; 1999 Dec; 9(6):661-8. PubMed ID: 10634129
[TBL] [Abstract][Full Text] [Related]
35. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers.
Meyer MR; Peters FT; Maurer HH
Drug Metab Dispos; 2008 Nov; 36(11):2345-54. PubMed ID: 18725511
[TBL] [Abstract][Full Text] [Related]
36. Characterization of benidipine and its enantiomers' metabolism by human liver cytochrome P450 enzymes.
Yoon YJ; Kim KB; Kim H; Seo KA; Kim HS; Cha IJ; Kim EY; Liu KH; Shin JG
Drug Metab Dispos; 2007 Sep; 35(9):1518-24. PubMed ID: 17537876
[TBL] [Abstract][Full Text] [Related]
37. Characterization of human liver cytochrome P450 enzymes involved in the metabolism of a new H+/K+-ATPase inhibitor KR-60436.
Ji HY; Lee HW; Kim HH; Choi JK; Lee HS
Toxicol Lett; 2005 Jan; 155(1):103-14. PubMed ID: 15585365
[TBL] [Abstract][Full Text] [Related]
38. Glucuronidation of anti-HIV drug candidate bevirimat: identification of human UDP-glucuronosyltransferases and species differences.
Wen Z; Martin DE; Bullock P; Lee KH; Smith PC
Drug Metab Dispos; 2007 Mar; 35(3):440-8. PubMed ID: 17151190
[TBL] [Abstract][Full Text] [Related]
39. Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.
Herraiz T; Guillén H; Arán VJ; Idle JR; Gonzalez FJ
Toxicol Appl Pharmacol; 2006 Nov; 216(3):387-98. PubMed ID: 16870220
[TBL] [Abstract][Full Text] [Related]
40. Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.
Shen HW; Wu C; Jiang XL; Yu AM
Biochem Pharmacol; 2010 Jul; 80(1):122-8. PubMed ID: 20206139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]